ArticlePloS one2025
FocusGate-Net: A dual-attention guided MLP-convolution hybrid network for accurate and efficient medical image segmentation.
Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Multi-scale feature integration with enhanced cytomorph for high-accuracy cervical cytology classification.PloS one · 2026Article
- Article
- DeepInsight-Net: a CBAM-enhanced ResNet50 framework with focal loss for robust cervical cancer classification on multi-center datasets.Frontiers in medicine · 2026Article
- DiagNeXt: A Two-Stage Attention-Guided ConvNeXt Framework for Kidney Pathology Segmentation and Classification.Journal of imaging · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Although recent advances in CNNs and Transformers have significantly improved medical image segmentation, these models often struggle to balance segmentation accuracy, inference speed, and architectural simplicity. Lightweight MLP-based methods have emerged as a promising alternative, but they frequently lack the ability to capture fine-grained spatial context, leading to suboptimal boundary localization. To address this issue, a hybrid architecture can be introduced that integrates the computational efficiency of MLPs with the spatial feature extraction strengths of convolutional or transformer-based modules. This design aims to deliver high segmentation accuracy while preserving low latency and minimal architectural complexity, thereby enhancing applicability in real-time clinical settings. Medical image segmentation remains a challenging task requiring both accuracy and computational efficiency in clinical settings. This paper introduces FocusGate-Net, a novel hybrid architecture combining shifted token MLP blocks, convolutional feature extractors, and dual-attention mechanisms for robust medical image segmentation. Our approach leverages the spatial dependency modeling capabilities of MLP architectures while enhancing feature selectivity through Convolutional Block Attention Module (CBAM) and Attention Gate (AG) mechanisms. We evaluate FocusGate-Net on three diverse medical image datasets: ISIC2018 for skin lesion segmentation, PH2 for dermatoscopic images, and Kvasir-SEG for polyp segmentation. Comprehensive ablation studies verify the contribution of each architectural component, demonstrating the effectiveness of our hybrid design. When benchmarked against state-of-the-art models like UNet, UNet++, and ResUNet, FocusGate-Net achieves superior performance, with a Dice coefficient of 92.47% and IoU of 86.36% on ISIC2018. Furthermore, our model demonstrates exceptional cross-dataset generalization capability, achieving Dice scores of 97.25% on PH2 and 94.83% on Kvasir-SEG. These results highlight the potential of MLP-based hybrid architectures with attention mechanisms for improving medical image segmentation accuracy while maintaining computational efficiency suitable for clinical deployment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.